Needs assessment and expected educational outcome

To update evaluations for iron deficiency and therapeutic iron supplementation, according to the new 2021 ESC/HFA Guidelines for Heart Failure; to gain insights from the AFFIRM-AHF trial; to learn about cost effectiveness of iron supplementation in HF patients; and to learn the effect of iron supplementation on exercise capacity and QoL.  

Learning objectives

After watching this webinar, participants will :

• be updated on the epidemiology of hypokalaemia and hyperkalaemia;
• learn when and how to monitor/measure K levels in heart failure; and
• learn how to evaluate management options in patients at risk of hyperkalaemia, including new therapies that may improve adherence and treatment optimisation in patients with heart failure and high K levels.

Main topic

• Heart Failure

Session information

This webinar is designed for general cardiologists and all healthcare professionals interested in Heart Failure.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).